BC
ALBO
Birchview Capital’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-117,000
| Closed | -$2.53M | – | 58 |
|
|
2022
Q4 | $2.53M | Hold |
117,000
| – | – | 1.79% | 12 |
|
|
2022
Q3 | $2.27M | Buy |
117,000
+4,000
| +4% | +$77.4K | 1.59% | 13 |
|
|
2022
Q2 | $2.24M | Hold |
113,000
| – | – | 1.63% | 12 |
|
|
2022
Q1 | $3.37M | Hold |
113,000
| – | – | 2.43% | 7 |
|
|
2021
Q4 | $2.63M | Hold |
113,000
| – | – | 1.7% | 11 |
|
|
2021
Q3 | $3.53M | Buy |
113,000
+2,000
| +2% | +$62.4K | 2.4% | 8 |
|
|
2021
Q2 | $3.91M | Hold |
111,000
| – | – | 2.34% | 8 |
|
|
2021
Q1 | $3.91M | Buy |
111,000
+19,000
| +21% | +$670K | 2.32% | 8 |
|
|
2020
Q4 | $3.45M | Buy |
92,000
+34,000
| +59% | +$1.28M | 1.99% | 9 |
|
|
2020
Q3 | $1.94M | Buy |
58,000
+10,000
| +21% | +$334K | 1.29% | 14 |
|
|
2020
Q2 | $1.27M | Hold |
48,000
| – | – | 0.77% | 20 |
|
|
2020
Q1 | $786K | Hold |
48,000
| – | – | 0.7% | 20 |
|
|
2019
Q4 | $1.22M | Buy |
48,000
+10,000
| +26% | +$254K | 0.89% | 18 |
|
|
2019
Q3 | $760K | Hold |
38,000
| – | – | 0.51% | 19 |
|
|
2019
Q2 | $1.23M | Hold |
38,000
| – | – | 0.75% | 13 |
|
|
2019
Q1 | $1.22M | Hold |
38,000
| – | – | 0.77% | 12 |
|
|
2018
Q4 | $932K | Hold |
38,000
| – | – | 0.88% | 13 |
|
|
2018
Q3 | $1.25M | Hold |
38,000
| – | – | 0.81% | 16 |
|
|
2018
Q2 | $1.35M | Buy |
38,000
+14,000
| +58% | +$497K | 0.92% | 13 |
|
|
2018
Q1 | $782K | Buy |
+24,000
| New | +$782K | 0.52% | 17 |
|